Patients with Deleterious Germline Variants in <i>STXBP2</i> Develop Toxicity after CAR-T Cell Therapy with Axicabtagene CiloleucelMark B. Leick, Marcela V. Maus, Kathleen Gallagher et al.|Blood|2022Cited by 3